- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06609317
Postpartum pElvic Assisted Recovery With Leva (PEARL)
Feasibility of Pelvic Floor Muscle Training With a Digital Therapeutic Motion-based Device (Leva Device) in a Postpartum Population
The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device.
In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum.
Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Katie Propst, MD
- Phone Number: 813-259-0655
- Email: katiepropst@usf.edu
Study Contact Backup
- Name: Maha Al Jumaily, MBBS
- Phone Number: 813-259-8680
- Email: mahaaljumaily@usf.edu
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33606
- Recruiting
- University of South Florida
-
Contact:
- Maha Al Jumaily, MBBS
- Phone Number: 813-259-8680
- Email: mahaaljumaily@usf.edu
-
Principal Investigator:
- Katie Propst, MD
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Recruiting
- Ohio State University Wexner Medical Center
-
Contact:
- Lisa Hickman, MD
- Phone Number: 614-293-4643
- Email: PEARLstudy@osumc.edu
-
Principal Investigator:
- Lisa Hickman, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Spontaneous vaginal delivery within the last 4-8 weeks
- Age ≥ 18 years
- Ambulatory
- Willing and able to consent to participate.
- English speaking
- Owns a smartphone
Exclusion Criteria:
- Operative or cesarean delivery
- Obstetric delivery at less than 20 weeks gestation
- Third- or fourth-degree perineal laceration
- Episiotomy
- Multiples
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Device Arm
Participants in this arm will use a digital therapeutic motion-based device for postpartum pelvic floor muscle training
|
This intervention includes use of a digital therapeutic motion-based device for pelvic floor muscle training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility
Time Frame: From enrollment to 6 months postpartum
|
Feasibility will be assessed using participant reported discomfort with device use, ease of device use, net promotor score, patient satisfaction, and free text feedback on the device.
|
From enrollment to 6 months postpartum
|
|
Perineal Pain
Time Frame: From enrollment to 6 months postpartum
|
Participants will complete validated surveys assessing perineal pain at baseline, 3 months postpartum, and 6 months postpartum.
|
From enrollment to 6 months postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bladder function
Time Frame: From enrollment to 6 months postpartum
|
Participants will complete validated surveys assessing bladder function at baseline, 3 months postpartum, and 6 months postpartum.
|
From enrollment to 6 months postpartum
|
|
Bowel Function
Time Frame: From enrollment to 6 months postpartum
|
Participants will complete validated surveys assessing bowel function at baseline, 3 months postpartum, and 6 months postpartum.
|
From enrollment to 6 months postpartum
|
|
Pelvic Organ Prolapse
Time Frame: From enrollment to 6 months postpartum
|
Participants will complete validated surveys assessing pelvic organ prolapse symptoms at baseline, 3 months postpartum, and 6 months postpartum.
|
From enrollment to 6 months postpartum
|
|
Vaginal pain
Time Frame: From enrollment to 6 months postpartum
|
Participants will complete validated surveys assessing vaginal pain at baseline, 3 months postpartum, and 6 months postpartum.
|
From enrollment to 6 months postpartum
|
|
Sexual function
Time Frame: From enrollment to 6 months postpartum
|
Participants will complete validated surveys assessing sexual function at 3 months postpartum and 6 months postpartum.
|
From enrollment to 6 months postpartum
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 007382
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.